Clinical Update - Debio 025 in Hepatitis C
...gen, these findings showed potent antiviral activity. The phase IIa study investigated the efficacy and safety of Debio 025 in combination with peg interferon alpha 2a (peg-IFNÿ±2a) and ribavirin in previously null-responder genotype 1 HCV patients. Results demonstrated that Debio 025 at doses o...Clinical Update - Debio 025 in Hepatitis C
...lind, placebo-controlled, parallel-group study will investigate the efficacy and safety of three different treatment regimens combining Debio 025 with peg interferon alpha 2a (peg-IFNalpha2a) and ribavirin in treatment-naive chronic HCV genotype 1 patients. During this 72 week trial, on top of the...Enzon to Present Preclinical Data From PEG-SN38 and PEGylation Technology Studies at AACR Meeting
...ats. (Poster displayed on Sunday, April 15, 2007, 1:00 PM - 5:00 PM, PT, Poster Section 30, Poster Board 10.) -- Abstract #4731: Customized positive peg linkers for the delivery of antisense molecules (Poster displayed on Tuesday, April 17, 2007, 1:00 PM - 5:00 PM, PT, Poster Section 25, Poster Board 1...